Corrigendum: The prevalence and clinical relevance of the DFS immunofluorescence staining pattern in a large ANA-positive cohort

Corrigendum: The prevalence and clinical relevance of the DFS immunofluorescence staining pattern in a large ANA-positive cohort

Bibliographic Details
Main Authors:	Chuiwen Deng, Anqi Wang, Chaojun Hu, Wen Zhang, Xiaofeng Zeng, Yunyun Fei
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Medicine
Subjects:	antinuclear antibody indirect immunofluorescence prevalence dense fine speckled pattern pathological conditions
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1216773/full

Similar Items

The Prevalence and Clinical Relevance of the DFS Immunofluorescence Staining Pattern in a Large ANA-Positive Cohort
by: Chuiwen Deng, et al.
Published: (2022-05-01)

The Nuclear Dense Fine Speckled (DFS) Immunofluorescence Pattern: Not All Roads Lead to DFS70/LEDGFp75
by: Evelyn S. Sanchez-Hernandez, et al.
Published: (2023-01-01)

Discriminating between Homogeneous (AC-1) and Dense Fine Speckled (AC-2) Antinuclear Antibody Patterns: Re-Evaluation of Immunofluorescence Imaging
by: Han-Hua Yu, et al.
Published: (2023-11-01)

Anti-dense fine speckled 70 (DFS70) autoantibodies: correlates and increasing prevalence in the United States
by: Gregg E. Dinse, et al.
Published: (2023-06-01)

Clinical significance of anti-dense fine speckled 70 antibody in patients with fibromyalgia
by: Jisoo Jeong, et al.
Published: (2019-03-01)

Clinical significance of anti-DFS70 in immunoinflammatory rheumatic diseases (review)
by: T. A. Panafidina, et al.
Published: (2023-03-01)

Detection of Specific Autoantibodies in Sera with Negative Antinuclear Antibody by Indirect Immunofluorescence Assay but Positive by Enzyme Immunoassay
by: Ronnachai Viriyataveekul, et al.
Published: (2019-05-01)

Detection of Specific Autoantibodies in Sera with Negative Antinuclear Antibody by Indirect Immunofluorescence Assay but Positive by Enzyme Immunoassay
by: Ronnachai Viriyataveekul, M.D., et al.
Published: (2019-05-01)

Prevalence of Anti-Dense Fine Speckled 70 Antibodies in Systemic Autoimmune Rheumatic Diseases and Healthy Controls: A Cross-sectional Study
by: MVNL Ram Mohan, et al.
Published: (2023-10-01)

Detection of antinuclear antibody in autoimmune connective tissue diseases: a comparison between immunofluorescence and solid-phase assay
by: Neveen A Kamel, et al.
Published: (2018-01-01)

Antibody to dense fine speckled 70 and its significance in a Sub-Himalayan population: A hospital-based study
by: Deepjyoti Kalita, et al.
Published: (2022-01-01)

Anti-DFS70 Antibodies for Differentiating Systemic Autoimmune Rheumatic Disease in Patients with Positive ANA Tests: A Systematic Review and Meta-Analysis
by: Chiao-Feng Cheng, et al.
Published: (2021-09-01)

Complex patterns on HEp-2 indirect immunofluorescence assay in a large sample referred for anti-cell autoantibodies detection
by: Wilton Ferreira S. Santos, et al.
Published: (2024-01-01)

Evaluation of autoantibodies in oral submucous fibrosis: A clinicopathological study
by: Nallan C S K Chaitanya, et al.
Published: (2023-01-01)

Immunofluorescence pattern of antinuclear antibody and its association with autoantibody profile in systemic lupus erythematosus
by: Sadia Sharmin, et al.
Published: (2016-08-01)

Antinuclear antibody-negative systemic lupus erythematosus
by: Krithiga Muralidharan, et al.
Published: (2023-01-01)

Anti-Nuclear antibodies: Current concepts and future direction for diagnosing connective tissue disease
by: K Gautam
Published: (2015-03-01)

Evaluación de la inmunohistoquímica para el diagnóstico de las enfermedades autoinmunes Evaluation of the immunohistochemistry for the diagnosis of autoimmune diseases
by: Mercedes Meléndez Minobis, et al.
Published: (2004-09-01)

Evaluation of the Accuracy of Estimated Endpoint Titer of NOVA View in Indirect Immunofluorescent Antinuclear Antibody Testing
by: Hae Weon Cho, et al.
Published: (2024-07-01)

Experiência da adoção do I e II Consensos Brasileiros de Fator Antinuclear por Imunofluorescência Indireta em Células HEp-2 em um hospital universitário Experience of an university hospital on the implementation of I and II Brazilian Consensuses for Standardization of ANA in HEp-2 Cells
by: Claudia Cilene Fernandes Correia Laurino, et al.
Published: (2009-04-01)

Standardizing initial dilution titers of antinuclear antibodies for the screening of systemic lupus erythematosus
by: Joseph Sushil Rao, et al.
Published: (2019-01-01)

Evaluation of the performance of immunoblot and immunodot techniques used to identify autoantibodies in patients with autoimmune diseases
by: EL Hassouni Youssef, et al.
Published: (2021-03-01)

Hep-2000 indirect immunofluorescence assay – An emerging screening tool for detection of antinuclear autoantibodies in various connective tissue disorders
by: Arpita Singh, et al.
Published: (2024-12-01)

Evaluation of a Fully Automated Antinuclear Antibody Indirect Immunofluorescence Assay in Routine Use
by: Hyun-Woo Choi, et al.
Published: (2020-12-01)

Analysis of Antinuclear Antibody Test Referral Patterns in a Tertiary Care Hospital over Three Years: A Retrospective Observational Study
by: MVNL RamMohan, et al.
Published: (2024-01-01)

V Brazilian consensus guidelines for detection of anti-cell autoantibodies on hep-2 cells
by: Wilson de Melo Cruvinel, et al.
Published: (2019-07-01)

Unusual direct immunofluorescence (DIF) pattern in pemphigus herpetiformis- A case report
by: Rawat Kavita, et al.
Published: (2023-01-01)

Low Prevalence of Anti-DFS70 Antibodies in Children With ANA-Associated Autoimmune Disease
by: Mirjam Freudenhammer, et al.
Published: (2022-03-01)

Comparative analysis of BIOCHIP mosaic-based indirect immunofluorescence with direct immunofluorescence in diagnosis of autoimmune bullous diseases: A cross-sectional study
by: P Arunprasath, et al.
Published: (2020-01-01)

Comparative analysis of BIOCHIP mosaic-based indirect immunofluorescence with direct immunofluorescence in diagnosis of autoimmune bullous diseases: A cross-sectional study
by: P Arunprasath, et al.
Published: (2021-01-01)

Relationship between the age and sex of the patient with the results of the indirect immunofluorescence test in patients with bullous dermatoses
by: Ninković-Baroš Đuka, et al.
Published: (2022-01-01)

Seroepidemiology and Risk Factors of Toxoplasmosis in High School Girls of Ilam in the Year 2012
by: maryam Kamran, et al.
Published: (2014-11-01)

Seroepidemiology and Risk Factors of Toxoplasmosis in High School Girls of Ilam in the Year 2012
by: maryam Kamran, et al.
Published: (2014-11-01)

The influence of demography and referral medical specialty on the detection of autoantibodies to HEP-2 cells in a large sample of patients
by: Wilton Ferreira Silva Santos, et al.
Published: (2022-08-01)

Diagnostic Utility of Immunofluorescence in Oral Lesions: a Systematic Review
by: Selva Arockiam, et al.
Published: (2024-09-01)

Detection of Toxoplasma gondii-Specific Antibodies in Dogs. A Comparative Study of Immunoenzymatic, Immunofluorescent and Haemagglutination Titers
by: Deise AO Silva, et al.
Published: (1997-11-01)

Immunofluorescent Antibody Test (IFAT) for Trypanosoma cruzi in dogs from urban and rural areas of Pelotas, RS
by: Charlene Nascimento dos Santos, et al.
Published: (2015-07-01)

Immunofluorescence Staining of Paraffin Sections Step by Step
by: Sami Zaqout, et al.
Published: (2020-11-01)

CORRELATION OF PEMPHIGUS VULGARIS ANTIBODY TITERS BY INDIRECT IMMUNOFLUORESCENCE WITH ACTIVITY OF DISEASE BASED ON PEMPHIGUS AREA AND ACTIVITY SCORE (PAAS)
by: H. Mortazavi, et al.
Published: (2008-06-01)

CORRELATION OF PEMPHIGUS VULGARIS ANTIBODY TITERS BY INDIRECT IMMUNOFLUORESCENCE WITH ACTIVITY OF DISEASE BASED ON PEMPHIGUS AREA AND ACTIVITY SCORE (PAAS)
by: H. Mortazavi, et al.
Published: (2008-06-01)